[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Axitinib Market Report 2017

March 2017 | 106 pages | ID: U475F98559EEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Axitinib

Revenue, means the sales value of Axitinib

This report studies sales (consumption) of Axitinib in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Pfizer
  • Allergan
  • Alnylam Pharmaceuticals
  • Amgen
  • Angstrom Pharmaceuticals
  • Acceleron Pharma
  • Biocon
  • Bionomics
  • CASI Pharmaceuticals
  • Celgene Corporation
  • Enzon Pharmaceuticals
  • Five Prime Therapeutics
  • Fujifilm Kyowa Kirin Biologics
  • Genentech
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
Split by applications, this report focuses on sales, market share and growth rate of Axitinib in each application, can be divided into
  • Application 1
  • Application 2
United States Axitinib Market Report 2017

1 AXITINIB OVERVIEW

1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Axitinib
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Axitinib (2012-2022)
  1.4.1 United States Axitinib Sales and Growth Rate (2012-2022)
  1.4.2 United States Axitinib Revenue and Growth Rate (2012-2022)

2 UNITED STATES AXITINIB COMPETITION BY MANUFACTURERS

2.1 United States Axitinib Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Axitinib Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Axitinib Average Price by Manufactures (2015 and 2016)
2.4 Axitinib Market Competitive Situation and Trends
  2.4.1 Axitinib Market Concentration Rate
  2.4.2 Axitinib Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES AXITINIB SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Axitinib Sales and Market Share by States (2012-2017)
3.2 United States Axitinib Revenue and Market Share by States (2012-2017)
3.3 United States Axitinib Price by States (2012-2017)

4 UNITED STATES AXITINIB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Axitinib Sales and Market Share by Type (2012-2017)
4.2 United States Axitinib Revenue and Market Share by Type (2012-2017)
4.3 United States Axitinib Price by Type (2012-2017)
4.4 United States Axitinib Sales Growth Rate by Type (2012-2017)

5 UNITED STATES AXITINIB SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Axitinib Sales and Market Share by Application (2012-2017)
5.2 United States Axitinib Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES AXITINIB MANUFACTURERS PROFILES/ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Axitinib Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.2 Axitinib Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Alnylam Pharmaceuticals
  6.3.2 Axitinib Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Amgen
  6.4.2 Axitinib Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Angstrom Pharmaceuticals
  6.5.2 Axitinib Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Acceleron Pharma
  6.6.2 Axitinib Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biocon
  6.7.2 Axitinib Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bionomics
  6.8.2 Axitinib Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 CASI Pharmaceuticals
  6.9.2 Axitinib Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Celgene Corporation
  6.10.2 Axitinib Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Enzon Pharmaceuticals
6.12 Five Prime Therapeutics
6.13 Fujifilm Kyowa Kirin Biologics
6.14 Genentech

7 AXITINIB MANUFACTURING COST ANALYSIS

7.1 Axitinib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Axitinib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Axitinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Axitinib Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AXITINIB MARKET FORECAST (2017-2022)

11.1 United States Axitinib Sales, Revenue Forecast (2017-2022)
11.2 United States Axitinib Sales Forecast by Type (2017-2022)
11.3 United States Axitinib Sales Forecast by Application (2017-2022)
11.4 Axitinib Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Axitinib
Table Classification of Axitinib
Figure United States Sales Market Share of Axitinib by Type in 2015
Table Application of Axitinib
Figure United States Sales Market Share of Axitinib by Application in 2015
Figure United States Axitinib Sales and Growth Rate (2012-2022)
Figure United States Axitinib Revenue and Growth Rate (2012-2022)
Table United States Axitinib Sales of Key Manufacturers (2015 and 2016)
Table United States Axitinib Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Axitinib Sales Share by Manufacturers
Figure 2016 Axitinib Sales Share by Manufacturers
Table United States Axitinib Revenue by Manufacturers (2015 and 2016)
Table United States Axitinib Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Axitinib Revenue Share by Manufacturers
Table 2016 United States Axitinib Revenue Share by Manufacturers
Table United States Market Axitinib Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Axitinib Average Price of Key Manufacturers in 2015
Figure Axitinib Market Share of Top 3 Manufacturers
Figure Axitinib Market Share of Top 5 Manufacturers
Table United States Axitinib Sales by States (2012-2017)
Table United States Axitinib Sales Share by States (2012-2017)
Figure United States Axitinib Sales Market Share by States in 2015
Table United States Axitinib Revenue and Market Share by States (2012-2017)
Table United States Axitinib Revenue Share by States (2012-2017)
Figure Revenue Market Share of Axitinib by States (2012-2017)
Table United States Axitinib Price by States (2012-2017)
Table United States Axitinib Sales by Type (2012-2017)
Table United States Axitinib Sales Share by Type (2012-2017)
Figure United States Axitinib Sales Market Share by Type in 2015
Table United States Axitinib Revenue and Market Share by Type (2012-2017)
Table United States Axitinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Axitinib by Type (2012-2017)
Table United States Axitinib Price by Type (2012-2017)
Figure United States Axitinib Sales Growth Rate by Type (2012-2017)
Table United States Axitinib Sales by Application (2012-2017)
Table United States Axitinib Sales Market Share by Application (2012-2017)
Figure United States Axitinib Sales Market Share by Application in 2015
Table United States Axitinib Sales Growth Rate by Application (2012-2017)
Figure United States Axitinib Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Axitinib Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Axitinib Sales Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Axitinib Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Axitinib Sales Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Angstrom Pharmaceuticals Axitinib Sales Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Axitinib Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Axitinib Sales Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Axitinib Sales Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table CASI Pharmaceuticals Axitinib Sales Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Corporation Axitinib Sales Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information List
Table Five Prime Therapeutics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Genentech Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Axitinib
Figure Manufacturing Process Analysis of Axitinib
Figure Axitinib Industrial Chain Analysis
Table Raw Materials Sources of Axitinib Major Manufacturers in 2015
Table Major Buyers of Axitinib
Table Distributors/Traders List
Figure United States Axitinib Production and Growth Rate Forecast (2017-2022)
Figure United States Axitinib Revenue and Growth Rate Forecast (2017-2022)
Table United States Axitinib Production Forecast by Type (2017-2022)
Table United States Axitinib Consumption Forecast by Application (2017-2022)
Table United States Axitinib Sales Forecast by States (2017-2022)
Table United States Axitinib Sales Share Forecast by States (2017-2022)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories